Roche’s MS test scores FDA breakthrough device designation
Roche’s Elecsys neurofilament light chain (NfL) test is used for detecting disease activity in multiple sclerosis.
09 November 2023
09 November 2023
Roche’s Elecsys neurofilament light chain (NfL) test is used for detecting disease activity in multiple sclerosis.
The agreement comes after Portrait Mobile received 510(k) clearance from the US FDA in August this year.
A third US patent for the 12-lead extended wear patch for identifying heart attacks and cardiac arrythmias has been secured by HeartBeam.
Jana Care’s quantitative blood testing platform is intended to facilitate self-administered blood tests at home.
The guidewire helps gather a wide range of key real-time data points to serve as a clinical decision support tool.
More than 200 patients who are ctDNA-positive, as determined by Signatera, will be randomised in the study.
Regulators worldwide are designing and implementing AI legislation to keep up with technology’s pace of development.
Further Group will tap into Massive Bio’s AI-powered platform to enhance clinical trial matching for cancer patients.
their healthcare decisions because they have access to information through various means, including the literature, the internet, and more recently, different types of connected medical devices. With the rise of mHealth apps, wearable technologies, and telemedicine, patients are well-situated to gain medical information, and ultimately make the best choices for their health.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Give your business an edge with our leading industry insights.